BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications

BACKGROUND: Mutations in the genes called BRCA1 and BRCA2 are associated with significantly elevated lifetime risk of developing breast and ovarian cancer. This year marks 25 years since genetic tests for BRCA1/2 mutations became available to the public. Currently, comprehensive guidelines exist reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrova, Dafina, Cruz, Maite, Sánchez, María-José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686063/
https://www.ncbi.nlm.nih.gov/pubmed/34920368
http://dx.doi.org/10.1016/j.breast.2021.12.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686063/
https://www.ncbi.nlm.nih.gov/pubmed/34920368
http://dx.doi.org/10.1016/j.breast.2021.12.005

Ejemplares similares